PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.
Tarih
2011Yazar
Flinn, I. W.
Leonard, J.
Reeves, J.
Ferhanoglu, B.
Doner, K. T.
Eom, H.
Raposo, J.
Chowhan, N. M.
Suh, C.
Noga, S.
Tumyan, G.
Aung, S.
Hajdenberg, J.
Ulrich, B. K.
Pendergrass, K. B.
Mulligan, G.
Rizo, A.
Kussick, S.
Offner, F.
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/142378https://doi.org/10.1200/jco.2011.29.15_suppl.tps226
Koleksiyonlar
- Makale [92796]